XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Comprehensive Income [Abstract]      
Net income $ 679,089 $ 744,844 $ 582,131
Other comprehensive income (loss), net of tax:      
Foreign currency translation adjustments (25,692) (26,731) 15,151
Defined benefit plans, net of tax expense of $(613) in 2022 (3,282) 0 0
Reclassification adjustment for defined benefit plans included in net income, net of tax of $99 in 2022 506 0 0
Unrealized gain (loss) on Euro-denominated notes, net of tax expense (benefit) of $1,411 in 2022, $2,011 in 2021 and $(2,325) in 2020 4,525 6,404 (7,378)
Unrealized gain (loss) on investments, net of tax expense (benefit) of $(14) in 2022, $46 in 2021 and $(120) in 2020 (46) 146 (382)
Unrealized gain (loss) on derivative instruments:      
Unrealized gain (loss) on foreign currency exchange contracts, net of tax expense (benefit) of $5,954 in 2022, $2,133 in 2021 and $(2,013) in 2020 14,851 9,139 (8,527)
Unrealized gain (loss) on cross currency swaps, net of tax expense (benefit) of $1,190 in 2022, $1,699 in 2021 and $(1,774) in 2020 3,817 5,399 (5,626)
Reclassification adjustment for (gain) loss included in net income, net of tax (expense) benefit of $(6,742) in 2022, $1,347 in 2021 and $(158) in 2020 (18,991) 5,774 (671)
Unrealized gain (loss) on derivative instruments (323) 20,312 (14,824)
Other comprehensive gain (loss), net of tax (24,312) 131 (7,433)
Comprehensive income 654,777 744,975 574,698
Less: comprehensive income attributable to noncontrolling interest 0 (1) 355
Comprehensive income attributable to IDEXX Laboratories, Inc. $ 654,777 $ 744,976 $ 574,343